Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin).

It is estimated that one-third of Americans use dietary herbal supplements on a regular basis. Diets rich in bioactive phytochemicals are associated with reduced risk of certain cancers, notably, colon cancer. Herbal supplements have not been directly tested as sources of bioactive cancer preventives. Hence, this study compares the ability of four herbal flavonoids (quercetin, curcumin, rutin and silymarin) and one whole herb mixture (ginseng powder) to suppress aberrant crypt foci (ACF) in an azoxymethane (AOM)-induced rat colon cancer model. Second, this study examines the effect of these herbal compounds on apoptosis and the mechanisms by which these compounds evoke apoptosis. The results of this study show that diets containing quercetin, curcumin, silymarin, ginseng and rutin decreased the number of ACFs by 4-, 2-, 1.8-, 1.5- and 1.2-fold, respectively compared with control. Histological analysis of the colon mucosa revealed that all the herbal supplements, except silymarin, induced apoptosis, with quercetin being the most potent (3x increase compared with control). Furthermore, ginseng and curcumin were region-specific in inducing apoptosis. The ability of quercetin and curcumin to modulate ACFs correlates well with their ability to induce apoptosis. Western blot analysis of caspase 9, Bax (proapoptotic) and Bcl-2 (antiapoptotic) proteins from the colon scraping suggests that quercetin and curcumin induce apoptosis via the mitochondrial pathway. Taken together, the results of this study suggest that these herbal supplements may exert significant and potentially beneficial effects on decreasing the amount of precancerous lesions and inducing apoptosis in the large intestine.

[1]  R. Agarwal,et al.  Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells , 2003, Oncogene.

[2]  P. Dolara,et al.  Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. , 2003, Cancer research.

[3]  Takuji Tanaka,et al.  Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane‐induced colon carcinogenesis in male F344 rats , 2002, International journal of cancer.

[4]  V. Steele,et al.  Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents. , 2002, Carcinogenesis.

[5]  A. Hara,et al.  Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker. , 2002, European Journal of Cancer Prevention.

[6]  A. Nishikawa,et al.  Spontaneous development of aberrant crypt foci in F344 rats. , 2002, Journal of experimental & clinical cancer research : CR.

[7]  D. Salvadori,et al.  Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[8]  Wei Li,et al.  Inhibition by ginseng of colon carcinogenesis in rats. , 2001, Journal of Korean medical science.

[9]  R. Dashwood,et al.  Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2‐amino‐3‐methylimidazo[4,5‐f]quinoline and treated post‐initiation with chlorophyllin , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[10]  S. Skinner,et al.  Non‐steroidal anti‐inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model 1 , 2000, Journal of gastroenterology and hepatology.

[11]  V. Steele,et al.  Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. , 2000, Carcinogenesis.

[12]  H. Daniel,et al.  Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. , 2000, Cancer research.

[13]  T. Sugimura,et al.  Suppression by Flavonoids of Cyclooxygenase‐2 Promoter‐dependent Transcriptional Activity in Colon Cancer Cells: Structure‐Activity Relationship , 2000, Japanese journal of cancer research : Gann.

[14]  M. Bertagnolli,et al.  Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. , 2000, Carcinogenesis.

[15]  V. Steele,et al.  Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. , 2000, The Journal of nutrition.

[16]  S. Fukushima,et al.  Inhibition by Ginseng of 1,2-Dimethylhydrazine Induction of Aberrant Crypt Foci in the Rat Colon , 2000, Nutrition and cancer.

[17]  V. Steele,et al.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.

[18]  J Ludbrook,et al.  MULTIPLE COMPARISON PROCEDURES UPDATED , 1998, Clinical and experimental pharmacology & physiology.

[19]  Tetsushi Watanabe,et al.  Active oxygens generation by flavonoids. , 1998, Biological & pharmaceutical bulletin.

[20]  V. Steele,et al.  Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  P. Hollman,et al.  Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.

[22]  G. Kuttan,et al.  Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.

[23]  L. Roncucci,et al.  Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy). , 1993, Cancer research.

[24]  T. P. Pretlow,et al.  Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. , 1992, Carcinogenesis.

[25]  D. Ahnen,et al.  Regional variability of colonocyte growth and differentiation in the rat , 1992, The Anatomical record.

[26]  A. Medline,et al.  Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. , 1991, Carcinogenesis.

[27]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[28]  S. Schwartz,et al.  The identification of monoclonality in human aberrant crypt foci. , 1999, Cancer research.

[29]  V. Steele,et al.  Growth kinetics and chemoprevention of aberrant crypts in the rat colon , 1992, Journal of cellular biochemistry. Supplement.

[30]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.